Bonnie Fendrock, M.S., M.B.A.

Bonnie Fendrock is an executive and entrepreneur with more than 35 years of experience in the biotechnology industry. With a general management background, Bonnie has held roles in corporate and business development, marketing, and program management from foundational and high growth biotechnology companies including Genzyme, Somatix, and Genetics Institute. Bonnie has worked in entrepreneurial environments where efficient execution to build new businesses is at a premium. Her technology experience includes biotherapeutics, gene therapy, biological medical devices, bioengineered tools, and chemistry-based delivery platforms.

Most recently, Bonnie Fendrock was the founding CEO of Cyta Tx, a spin-out from UMass, Amherst. Prior to Cyta Tx, Bonnie was CEO, Co-founder and Board Member of Hepregen Corporation, a venture backed, commercial stage, MIT spin-out. In 2012, Bonnie was honored along with other innovation leaders as one of the Mass High Tech’s ‘Women to Watch’.

For the past five years, Bonnie served on the Commercial Advisory Committee of the Gloucester Marine Genomics Institute (GMGI). Bonnie is a Board Member of Wellspring House, a Gloucester-based non-profit supporting individuals and families to gain financial sustainability through job training and education. She is also a Trustee of Awesome Gloucester which provides microgrants to benefit the Gloucester community.

Prior to business school, Bonnie worked in research and product development at Integrated Genetics, Centocor and MIT. Bonnie received her BA, Molecular Biology from Wellesley College, MS, Interdisciplinary Science from MIT, and MBA from The Wharton School, University of Pennsylvania as a Management of Technology Fellow.